Inventors:
James Lillie - Westin MA, US
Manjula Gannavarapu - Acton MA, US
Karen Glatt - Natick MA, US
Sebastian Hoersch - Arlington MA, US
Shubhangi Kamatkar - Newton MA, US
Maureen Mertens, Hattersley - Stow MA, US
John E. Monahan - Walpole MA, US
Vickesh Myer - Harvard MA, US
Youzhen Wang - Newton MA, US
Yongyao Xu - Belmont MA, US
Xumei Zhao - Wayland MA, US
Rachel E. Meyers - Newton MA, US
Gabriel N. Hortobagyi - Houston TX, US
Lajos Pusztai - Bellaire TX, US
Assignee:
Millennium Pharmaceuticals, Inc. - Cambridge MA
Board of Regents, University of Texas System - Austin TX
International Classification:
C07K 1/00, C07K 14/00, C07K 17/00, C07H 1/00, C07H 5/00, C07H 21/00, C08B 37/00
US Classification:
530350, 536 111, 536 187, 536 231, 536 234, 536 235
Abstract:
The invention relates to newly discovered nucleic acid molecules and proteins associated with breast cancer. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers are provided.